VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
AJG
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
AJGArthur J. Gallagher & Co.
$226.01$58.1B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksAJGFinancials

Arthur J. Gallagher & Co. (AJG) Financials

30Y historyFree accessUpdated daily

Revenue growth accelerated to 27.6% in 2026Q1, supported by a robust underwriting efficiency reflected in a 74.4% combined ratio.

AJG Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Revenue14.97B13.94B11.55B10.07B8.55B8.21B7.01B7.12B6.92B6.25B5.68B5.39B4.63B3.18B2.52B2.13B1.86B1.73B1.65B1.62B1.47B1.43B1.44B1.22B1.06B888M800.58M713.53M582.77M524.6M449.7M
Revenue Growth %24.5%20.66%14.72%17.79%4.16%17.12%-1.55%2.83%10.86%9.95%5.34%16.55%45.51%26.16%18.06%14.51%7.8%5.12%1.34%10.42%2.88%-0.56%17.68%15.17%19.4%10.92%12.2%22.44%11.09%16.66%6.06%
Medical Costs & Claims5.09B6.31B6.68B5.83B4.95B5.23B4.5B4.83B4.98B4.52B4.08B3.78B3.23B2.12B1.6B1.36B1.18B1.07B381.2M437M416.3M473.4M267.9M251.8M230.4M197.5M232.07M220.82M184.91M256M146.4M
Medical Cost Ratio %34.01%45.25%57.78%57.85%57.93%63.75%64.2%67.85%71.98%72.36%71.79%70.11%69.74%66.75%63.68%63.62%63.38%61.8%23.17%26.92%28.32%33.13%18.64%20.62%21.73%22.24%28.99%30.95%31.73%48.8%32.56%
Gross Profit9.88B7.63B4.88B4.25B3.6B2.98B2.51B2.29B1.94B1.73B1.6B1.61B1.4B1.06B915.3M776.6M682.7M660.6M1.26B1.19B1.05B955.5M1.17B969.3M829.9M690.5M568.51M492.71M397.86M268.6M303.3M
Gross Margin %65.99%54.75%42.22%42.15%42.07%36.25%35.8%32.15%28.02%27.64%28.21%29.89%30.26%33.25%36.32%36.38%36.62%38.2%76.83%73.08%71.68%66.87%81.36%79.38%78.27%77.76%71.01%69.05%68.27%51.2%67.44%
Gross Profit Growth %-56.47%14.91%18.01%20.89%18.6%9.63%17.99%12.37%7.72%-0.58%15.14%32.41%15.51%17.86%13.75%3.35%-47.73%6.53%12.57%10.29%-18.27%20.61%16.8%20.19%21.46%15.38%23.84%48.12%-11.44%3.66%
Operating Expenses7.16B5.08B2.6B2.39B1.93B1.64B1.47B1.54B1.32B1.21B1.13B1.17B1B714.5M623.6M534.2M447.7M416.9M1.07B970.2M890.8M800M922.3M768.5M634.9M538.2M434.77M365.69M331.8M183M260.4M
OpEx / Revenue %47.83%36.47%22.47%23.69%22.58%19.96%20.96%21.67%19.1%19.45%19.84%21.79%21.66%22.47%24.74%25.02%24.02%24.11%65.14%59.77%60.59%55.99%64.18%62.94%59.88%60.61%54.31%51.25%56.94%34.88%57.91%
Depreciation & Amortization1.21B1.12B842.3M696.5M599.6M566.3M562.4M474.4M419M385.8M350.8M334.2M258.9M178.6M140.4M115.2M93.1M85.6M73.7M65.3M60.7M56.6M63.3M48.7M35.8M23.15M19.43M17.68M13.39M11.6M10.7M
Combined Ratio %81.83%81.72%80.25%81.54%80.51%83.71%85.16%89.52%91.09%91.81%91.63%91.89%91.4%89.22%88.43%88.64%87.39%85.91%88.32%86.69%88.91%89.12%82.83%83.56%81.61%82.85%83.29%82.2%88.67%83.68%90.46%
Operating Income2.72B2.55B2.28B1.86B1.67B1.34B1.04B745.9M617.2M511.4M475.5M437.1M398M342.8M291.7M242.4M235M243.7M192.2M216.1M163M155.5M246.8M200.8M195M152.3M133.74M127.02M66.05M85.6M42.9M
Operating Margin %18.17%18.28%19.75%18.46%19.49%16.29%14.84%10.48%8.91%8.19%8.37%8.11%8.6%10.78%11.57%11.36%12.61%14.09%11.68%13.31%11.09%10.88%17.17%16.44%18.39%17.15%16.71%17.8%11.33%16.32%9.54%
Operating Income Growth %-11.69%22.75%11.53%24.67%28.53%39.46%20.85%20.69%7.55%8.79%9.82%16.1%17.52%20.34%3.15%-3.57%26.8%-11.06%32.58%4.82%-36.99%22.91%2.97%28.04%13.88%5.29%92.3%-22.83%99.53%-7.54%
EBITDA3.93B3.67B3.12B2.56B2.27B1.9B1.6B1.22B1.04B897.2M826.3M771.3M656.9M521.4M432.1M357.6M328.1M329.3M265.9M281.4M223.7M212.1M310.1M249.5M230.8M175.45M153.16M144.7M79.45M97.2M53.6M
EBITDA Margin %26.24%26.33%27.04%25.37%26.51%23.18%22.86%17.14%14.97%14.37%14.55%14.3%14.2%16.4%17.14%16.75%17.6%19.04%16.16%17.34%15.22%14.84%21.58%20.43%21.77%19.76%19.13%20.28%13.63%18.53%11.92%
Interest Expense638.4M638.8M381.3M296.7M256.9M226.1M196.4M179.8M138.4M124.1M109.8M103M89M50.1M43M40.8M34.6M28.5M28.6M000000000000
Non-Operating Income40.3M10.2M26M377.3M83M135.8M-27.1M-60M-600K27.5M32.1M40.6M17.5M1.7M3.4M-6.2M-2.6M4.1M0000000000000
Pretax Income2.04B1.87B1.87B1.19B1.33B975.1M870.9M626.1M479.4M359.8M333.6M293.5M291.5M291M245.3M207.8M203M211.1M163.6M200.1M154.5M12.9M237.3M192.8M185.5M141.8M133.74M127.02M86.99M85.7M67M
Pretax Margin %13.63%13.42%16.23%11.77%15.52%11.88%12.42%8.79%6.92%5.76%5.87%5.44%6.3%9.15%9.73%9.73%10.89%12.21%9.95%12.33%10.51%0.9%16.51%15.79%17.5%15.97%16.71%17.8%14.93%16.34%14.9%
Income Tax424.5M368.3M404.4M219.1M211M20.1M12.8M-89.7M-196.5M-157.1M-96.7M-95.6M-36M6.4M50.3M63.7M39.7M78M52.2M45.5M26.1M-26.2M47.8M46.9M55.6M16.5M40.78M43.78M28.31M28.1M22.8M
Effective Tax Rate %20.8%19.68%21.57%18.49%15.9%2.06%1.47%-14.33%-40.99%-43.66%-28.99%-32.57%-12.35%2.2%20.51%30.65%19.56%36.95%31.91%22.74%16.89%-203.1%20.14%24.33%29.97%11.64%30.5%34.47%32.54%32.79%34.03%
Net Income1.61B1.49B1.46B969.5M1.11B906.8M818.8M668.8M633.5M481.3M396.8M356.8M303.4M268.6M195M144.1M174.1M128.6M77.3M138.8M128.5M30.8M188.5M146.2M129.9M125.3M92.95M83.24M58.68M57.6M44.2M
Net Margin %10.76%10.72%12.66%9.63%13.03%11.05%11.68%9.39%9.15%7.71%6.99%6.62%6.56%8.45%7.74%6.75%9.34%7.44%4.7%8.55%8.74%2.16%13.12%11.97%12.25%14.11%11.61%11.67%10.07%10.98%9.83%
Net Income Growth %3.39%2.13%50.87%-12.99%22.87%10.75%22.43%5.57%31.62%21.3%11.21%17.6%12.96%37.74%35.32%-17.23%35.38%66.36%-44.31%8.02%317.21%-83.66%28.93%12.55%3.67%34.8%11.67%41.85%1.88%30.32%4.25%
EPS (Diluted)6.205.756.534.425.194.374.203.523.402.542.322.061.972.061.591.281.611.280.821.431.310.321.991.571.411.391.040.870.770.800.64
EPS Growth %-4.77%-11.94%47.74%-14.84%18.76%4.05%19.32%3.53%33.86%9.48%12.62%4.57%-4.37%29.56%24.22%-20.5%25.78%56.1%-42.66%9.16%309.38%-83.92%26.75%11.35%1.44%33.65%19.54%12.99%-3.75%25%4.92%
EPS (Basic)-5.836.634.515.304.474.293.603.472.572.332.071.972.081.611.281.611.280.831.451.320.322.051.621.471.471.110.920.810.800.64
Diluted Shares Outstanding259.82M260.34M223.9M219.3M214.7M207.3M195M190.1M186.16M182.12M178.39M173.22M154.26M130.47M122.48M112.47M108.4M100.63M94.27M97.06M98.09M96.1M94.5M93.12M92.13M90.14M89.38M95.68M76.21M72M69.06M

Key Metrics

Growth RegimeAccelerating
ProfitabilityStrong
Balance SheetHealthy
Cash FlowRobust
Top Statement Risk

Integration and wage inflation

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Revenue Growth Outpacing Historical Norms

As reported in recent financial statements, AJG achieved a significant revenue growth rate of 27.6% in 2026Q1, suggesting that the firm's aggressive acquisition strategy and middle-market focus are successfully capturing market share despite broader economic headwinds that have historically pressured insurance brokerage top-line performance across the industry.

The acceleration in revenue growth appears to be driven by both organic expansion and the successful integration of larger-scale acquisitions like the Willis Re assets. Investors should monitor whether this growth trajectory remains sustainable as the firm moves further into the more volatile reinsurance brokerage space.

Underwriting Efficiency and Margin Resilience

Based on reported figures, AJG maintained a combined ratio of 74.4% in 2026Q1, which indicates robust underwriting profitability and suggests that the firm's decentralized branch structure effectively manages operational costs even as the company scales its global footprint through high-frequency M&A activity in the current market.

The significant improvement in the combined ratio compared to the 90.6% reported in 2025Q4 suggests that the company is successfully leveraging its scale to drive margin expansion. This performance warrants further investigation into whether these efficiencies are structural or if they are being temporarily bolstered by favorable seasonal commission timing.

Strategic Pivot to Reinsurance Markets

According to recent SEC filings, the company's transition into the reinsurance brokerage space represents a material inflection point, evidenced by the 2026Q1 net income of $822.0M, which suggests that the firm is successfully diversifying its revenue base beyond its traditional middle-market brokerage and risk management segments.

This shift into reinsurance introduces a higher degree of volatility compared to the firm's historical focus on middle-market accounts. Analysts should evaluate whether the current profitability levels can be maintained if the reinsurance market experiences a cyclical downturn or increased pricing pressure from global competitors.

Earnings Volatility and Acquisition Integration

Financial data reveals significant quarterly fluctuations in net income, such as the $32.2M loss in 2023Q4 followed by strong recovery, which suggests that AJG's reliance on acquisition-related accounting adjustments may mask the underlying operational performance and create potential risks for investors relying on headline earnings metrics.

The volatility in EPS, ranging from a loss of $0.15 to a high of $3.16 over the observed period, indicates that integration costs and earn-out payables remain a primary source of earnings noise. Investors should remain cautious regarding the sustainability of these margins until the firm demonstrates consistent, non-acquisition-driven profitability.

AJG — Frequently Asked Questions

Quick answers to the most common questions about buying AJG stock.

What was Arthur J. Gallagher & Co.'s (AJG) revenue in 2025?

For fiscal year 2025, Arthur J. Gallagher & Co. (AJG) reported total revenue of $13.94B. This represents a 3000.2% increase compared to $449.7M in 1996.

Is Arthur J. Gallagher & Co. (AJG) profitable?

Arthur J. Gallagher & Co. (AJG) is profitable, generating $1.49B in net income for the fiscal year ending 2025 with a net profit margin of 10.7%.

What is Arthur J. Gallagher & Co.'s operating profit margin?

Arthur J. Gallagher & Co. (AJG) reported an operating income of $2.55B, resulting in an operating profit margin of 18.3%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Arthur J. Gallagher & Co.'s gross profit and gross margin?

Arthur J. Gallagher & Co. (AJG) generated $7.63B in gross profit for the year, representing a gross profit margin of 54.8%. This demonstrates the company's core pricing power and production efficiency.